Biodesix, Inc. (BDSX) Financials

BDSX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 99.1 million 94.5 million
2023-09-30 86.8 million 88.2 million
2023-06-30 77.6 million 84.6 million
2023-03-31 80.8 million 76.2 million

BDSX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -14.5 million 1.1 million
2023-09-30 -9.7 million 954000
2023-06-30 -5.5 million 1.1 million
2023-03-31 -15.4 million 2.3 million

BDSX Net Income

No data available :(

BDSX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 26.4 million - 25.4 million
2023-09-30 19.8 million - 25.7 million
2023-06-30 17.4 million - 20.3 million
2023-03-31 25.3 million - 13.8 million

BDSX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 92.3 million
2023-09-30 79.7 million
2023-06-30 78.5 million
2023-03-31 77.8 million

BDSX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 3.0 million 1.9 million 16.3 million -
2023-09-30 5.9 million 1.9 million 15.5 million -
2023-06-30 6.5 million 2.9 million 16.7 million -
2023-03-31 7.7 million 3.3 million 19.0 million 19.0 million

BDSX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 14.7 million 3.4 million
2023-09-30 13.5 million 3.2 million
2023-06-30 11.9 million 3.2 million
2023-03-31 9.1 million 3.2 million

BDSX

Price: $1.24

52 week price:
1.03
2.21

Earnings Per Share: -0.64 USD

P/E Ratio: -2.26

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 306900

Market Capitalization: 135.7 million

Links: